iHuman Inc.

As of March 31, 2026, iHuman Inc. carries a market capitalization of 87.15M, placing it among publicly traded companies globally. Its enterprise value stands at -70.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

iHuman Inc.'s next confirmed earnings release is scheduled for December 17, 2026.

As of March 31, 2026, iHuman Inc. has 51.11M shares outstanding.

As of March 31, 2026, iHuman Inc. trades at a trailing price-to-earnings ratio of 8.20. The price-to-sales ratio is 0.77, and the price-to-book ratio stands at 0.63.

As of March 31, 2026, iHuman Inc. maintains a current ratio of 3.50, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, iHuman Inc. posted a return on equity (ROE) of 7.73, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 3.49 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.44, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.63, useful for judging operating efficiency across full business cycles. The company generates approximately 176,347.37 in revenue per employee across its workforce of 640.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 10.83 indicates how many times iHuman Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, iHuman Inc. recorded 480,753.90 in income tax expense. That works out to an effective tax rate of 4.32, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 11.12M, leaving 10.64M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, iHuman Inc.'s stock has declined approximately 58.84% over the past 52 weeks. The 50-day moving average sits at 1.19, while the 200-day moving average is 1.54.

Over the twelve months ended March 31, 2026, iHuman Inc. generated 112.95M in revenue and converted that into 10.64M in net income, yielding earnings per share of 0.20. EBITDA reached 5.08M, while operating income came in at 5.08M.

As of March 31, 2026, iHuman Inc. holds 159.47M in cash and equivalents against 1.59M in total debt, resulting in a net debt position of -51.68M. Total book value stands at 139.04M, with working capital of 130.34M providing operational flexibility.

Over the twelve months ended March 31, 2026, iHuman Inc. posted a gross margin of 67.49, reflecting its pricing power and cost economics. The operating margin of 4.50 and net profit margin of 9.42 provide insight into operational efficiency.

As of March 31, 2026, iHuman Inc. has an Altman Z-Score of 2.51, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.